The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia

Blood Cancer J. 2019 Jan 15;9(2):5. doi: 10.1038/s41408-018-0169-1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't